Welcome to our dedicated page for Solana Company SEC filings (Ticker: HSDT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Solana Company filings document a Delaware issuer with Nasdaq-listed Class A common stock and a business profile that includes a Solana (SOL) digital asset treasury following its history as Helius Medical Technologies. Recent 8-K reports cover operating results, staking-reward revenue, digital-asset fair value effects, capital actions, registered-direct equity financing, put-option arrangements, and outstanding common stock and pre-funded warrants.
Governance filings include director and officer changes, separation and employment arrangements, board composition, and definitive proxy materials for annual-meeting matters, executive compensation, equity awards, and shareholder voting items. The filings also describe the company’s expansion from its medical-device neurotechnology legacy into SOL holdings, staking, custody, and related infrastructure initiatives.
Solana Company amended and restated its at-the-market stock sales agreement with Clear Street LLC and Maxim Group LLC, increasing the maximum aggregate offering price of Class A common shares in the program from $92.8 million to $250 million. The company uses a shelf registration on Form S-3 and a new prospectus supplement to support these sales. As of May 29, 2026, it has previously sold shares for aggregate gross proceeds of $24,657,697.51 under the prior agreement and prospectus supplement, which will no longer be used. Sales, if any, will be made from time to time at the company’s discretion, with the agents earning up to 3.00% of gross proceeds and receiving reimbursement of certain legal expenses.
Solana Company is offering shares of Class A common stock having an aggregate offering price of up to $250,000,000 pursuant to an amended and restated sales agreement with Clear Street LLC and Maxim Group LLC dated May 29, 2026.
The offering may be made from time to time as an at‑the‑market (ATM) program or by negotiated transactions; sales agents may receive up to 3.0% of gross proceeds. The company intends to use net proceeds, together with existing cash, to accumulate SOL tokens, for working capital and general corporate purposes. The prospectus supplement states 177,510,127 shares would be outstanding after an illustrative sale based on an assumed price of $2.04 per share.
Solana Co director Sergio Mello reported equity compensation awards from the company. He received 6,360 shares of Class A Common Stock as restricted stock units granted at no cash cost, bringing his directly held common shares reported in this filing to 6,360.
He was also granted stock options for 18,564 shares of Class A Common Stock at an exercise price of $2.36 per share, with 18,564 derivative securities reported as held after the grant. Both the RSUs and options vest in twelve equal monthly installments over one year, conditioned on his continued service through each vesting date.
Solana Co director Lee Michel Kai Tai received new equity awards as part of compensation. He was granted 6,360 restricted stock units of Class A Common Stock and a stock option for 18,564 shares at an exercise price of $2.3600 per share.
The RSUs and options both vest in twelve equal monthly installments on the last day of each month, fully vesting one year after the grant date, subject to continued service. After these awards, he holds 6,360 Class A shares and 18,564 options directly.
Solana Co director Edward M. Straw reported equity awards in the company’s Class A Common Stock. He received 6,360 restricted stock units that vest in twelve equal monthly installments over one year, subject to continued service. He was also granted options on 18,564 shares at an exercise price of $2.36 per share, vesting monthly over the same one-year period and expiring in 2036. Following the RSU grant, his direct common stock holdings total 8,542 shares.
Solana Co director Walter Blane received new equity awards. He was granted 6,360 shares of Class A Common Stock in the form of restricted stock units and 18,564 stock options with an exercise price of $2.3600 per share.
The RSUs and options each vest in twelve equal monthly installments, fully vesting on the one-year anniversary of the May 21, 2026 grant date, subject to continued service. Following the RSU grant, Blane directly holds 8,542 Class A Common shares, and the options are exercisable into 18,564 shares until their expiration on May 20, 2036.
STRAW EDWARD M reported acquisition or exercise transactions in this Form 4 filing.
Solana Co director Edward M. Straw received a grant of 2,180 shares of Class A Common Stock as restricted stock units under the company’s 2022 Equity Incentive Plan. The award carries no purchase price and increased his direct holdings to 2,182 shares following the transaction.
According to the terms, 75% of the RSUs vested on March 31, 2026, and the remaining 25% are scheduled to vest on June 30, 2026, conditioned on his continued service. The amendment also notes three reverse stock splits in 2023 and 2025 and explains that the reported share numbers have been adjusted because the initial Form 4 did not reflect these splits.
Walter Blane reported acquisition or exercise transactions in this Form 4 filing.
Solana Co director Walter Blane received an equity award of 2,180 shares of Class A common stock, reported as a grant or award at a price of $0.00 per share. Following this grant, he directly holds 2,182 shares.
The award represents restricted stock units under Solana Co’s 2022 Equity Incentive Plan. According to the terms, 75% of the RSUs vested on March 31, 2026 and the remaining 25% will vest on June 30, 2026, subject to his continued service. The amendment also notes three prior reverse stock splits, and the share numbers have been adjusted to reflect those splits after the initial Form 4 omitted them.
Solana Company’s large shareholder Pantera updated its ownership after exercising low-priced warrants. On May 21, 2026, Pantera Blockchain Fund exercised Strategic Advisory Warrants for 1,100,000 Class A shares at an exercise price of $0.01 per share, paying the issuer $1,100 in cash.
After this transaction, Pantera, through its managed funds and Daniel W. Morehead, may be deemed to beneficially own 4,997,319 shares of Solana Company Class A Common Stock, or about 8.4% of the outstanding shares based on 58,386,675 shares outstanding as of May 12, 2026, adjusted for the warrant exercise.
Solana Company reported results from its annual stockholder meeting held on May 21, 2026. Stockholders elected four directors, each to serve a one-year term ending at the 2027 annual meeting, with votes for individual nominees ranging from 13,334,028 to 13,523,716 and broker non-votes of 15,063,041 for each.
Stockholders also ratified the appointment of CBIZ CPAs P.C. as independent registered public accounting firm for the year ending December 31, 2026, with 28,738,836 votes for, 47,612 against and 67,199 abstentions, plus 15,063,041 broker non-votes. In addition, two more directors were elected for one-year terms, and the audit committee was reconstituted to include Blane Walter (Chair), Edward M. Straw and Michel Lee.